Ocular Therapeutix, Inc. logo OCUL - Ocular Therapeutix, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 16
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $25.50 DETAILS
HIGH: $30.00
LOW: $21.00
MEDIAN: $25.50
CONSENSUS: $25.50
UPSIDE: 209.84%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue 51.8 63.7 58.4 51.5 43.5 17.4 4.2 2.0 1.9 1.9 1.8 0.8 0 0.0
Cost of Revenue 6.6 5.6 5.3 4.5 4.4 2.1 2.3 0.5 0.5 0.4 0.3 0.1 10.5 0.0
Gross Profit 45.2 58.1 53.2 47.0 39.1 15.3 1.9 1.5 1.5 1.4 1.4 0.7 (10.5) 0.0
Operating Expenses
R&D Expenses 197.1 127.6 61.1 53.5 50.1 28.7 41.1 36.9 30.9 27.1 26.6 18.9 10.5 11.5
SG&A Expenses 118.3 102.2 74.5 72.1 67.1 49.5 46.6 23.7 32.5 17.7 13.0 8.9 2.4 2.1
Other Expenses 0 0 0 0 0 0 0 0 0.0 (0.0) 0.0 0 0.0 (0.0)
Operating Expenses 315.4 229.9 135.5 125.6 117.2 78.2 87.7 60.6 63.4 44.8 39.6 27.8 12.9 13.7
Operating Income
Operating Income (270.0) (171.8) (82.4) (78.7) (78.0) (62.8) (85.8) (59.1) (61.9) (43.3) (38.2) (27.1) (12.9) (13.7)
Interest Expense 11.8 13.6 11.3 7.0 6.7 6.8 6.1 1.7 1.9 1.7 1.7 1.1 0.4 0.4
Interest Income 18.4 20.3 4.0 0.8 0.0 0.2 1.2 0.9 0.4 0.3 0.2 0.0 0.0 0.0
Profitability
EBITDA (249.8) (176.1) (66.4) (61.9) 2.5 (146.1) (77.7) (56.0) (59.9) (42.1) (37.3) (27.0) (12.5) (13.3)
EBIT (254.1) (179.9) (69.4) (64.0) 0.1 (148.9) (80.3) (58.2) (61.5) (43.0) (38.0) (27.5) (12.9) (13.7)
Income Before Tax (265.9) (193.5) (80.7) (71.0) (6.6) (155.6) (86.4) (60.0) (63.4) (44.7) (39.7) (28.6) (13.3) (14.1)
Income Tax Expense 0 0 0 0 0 0 0 (2.3) 0.3 0 0 0.1 0 0
Net Income (265.9) (193.5) (80.7) (71.0) (6.6) (155.6) (86.4) (57.7) (63.4) (44.7) (39.7) (28.6) (13.3) (14.1)
Per Share Data
EPS (Basic) -1.42 -1.22 -1.09 -1.04 -1.05 -2.56 -1.91 -1.57 -2.20 -1.80 -1.71 -2.69 -4.52 -4.78
EPS (Diluted) -1.42 -1.22 -1.02 -0.97 -0.98 -2.56 -1.91 -1.57 -2.20 -1.80 -1.71 -2.69 -4.52 -4.78
Shares Outstanding 187.2 158.3 79.8 76.9 76.4 60.8 45.3 38.1 28.8 24.8 23.2 10.7 3.0 3.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 737.1 392.1 195.8 102.3 164.2 228.1 54.4 54.1 41.5 32.9
Short-Term Investments 0 0 0 0 0 0 0 0 0 35.2
Net Receivables 30.6 32.4 26.2 21.3 21.1 12.3 2.5 0.2 0.2 0.2
Inventory 3.6 3.0 2.3 2.0 1.2 1.2 1.0 0.2 0.1 0.1
Other Current Assets 10.9 13.5 7.9 4.0 0 0 0 1.7 0.1 1.4
Total Current Assets 782.1 441.0 232.2 129.6 191.3 246.2 60.2 56.2 43.3 69.9
Non-Current Assets
Property, Plant & Equipment 24.3 15.3 18.2 17.9 11.8 13.9 16.8 10.2 10.5 3.3
Goodwill 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 1.6 0 0 0 0 0 0 6.6 1.6 1.7
Other Non-Current Assets 0 1.6 1.6 1.8 1.8 1.8 1.8 0 0 0
Total Non-Current Assets 25.9 16.9 19.8 19.7 13.6 15.7 18.6 16.9 12.1 5.0
Total Assets 808.1 457.9 252.1 149.3 204.9 261.9 78.7 73.0 55.4 74.9
Current Liabilities
Account Payables 4.2 4.2 4.4 5.1 4.6 2.7 3.3 3.0 3.6 2.1
Short-Term Debt 2.8 0 0 0 0 8.3 0 0 5.5 1.5
Deferred Revenue 0 0.1 0.3 0.6 0 0 0 0 0 0
Other Current Liabilities 25.9 0 0 0 0 0 0 2.6 1.4 0
Total Current Liabilities 50.8 41.4 34.9 31.4 26.3 26.7 12.0 9.2 13.4 8.3
Non-Current Liabilities
Long-Term Debt 74.2 68.5 74.9 54.0 51.4 41.2 49.3 24.8 12.5 14.1
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 12.0 13.4 30.1 6.4 20.2 98.3 12.1 3.2 3.4 0.5
Total Non-Current Liabilities 102.9 101.2 126.0 82.5 90.6 159.1 70.3 28.0 15.9 14.6
Total Liabilities 153.7 142.6 160.9 113.9 116.9 185.8 82.4 37.2 29.3 22.9
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (1,157.0) (891.1) (697.6) (616.8) (545.8) (539.3) (383.6) (297.2) (237.3) (173.9)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 (0.0)
Total Stockholders' Equity 654.3 315.3 91.1 35.4 88.0 76.1 (3.6) 35.9 26.1 52.0
Total Liabilities & Equity 808.1 457.9 252.1 149.3 204.9 261.9 78.7 73.0 55.4 74.9
Debt Metrics
Total Debt 79.8 75.8 83.4 64.3 59.0 58.4 59.3 24.8 18.0 15.6
Net Debt (657.3) (316.3) (112.4) (38.0) (105.2) (169.6) 4.9 (29.3) (23.5) (17.3)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (265.9) (193.5) (80.7) (71.0) (6.6) (155.6) (86.4) (60.0) (63.4) (44.7)
Depreciation & Amortization 4.3 3.8 3.0 2.1 2.4 2.8 2.5 2.3 1.6 0.9
Stock-Based Compensation 43.2 33.1 17.8 17.0 15.0 7.5 8.8 7.5 7.3 6.0
Change in Working Capital 7.7 (10.2) (7.4) 1.3 (2.9) 1.2 (1.9) 0.6 3.5 2.1
Other Non-Cash Items 5.8 32.2 (2.9) (9.0) (73.5) 4.4 3.7 0.4 0.4 0.4
Operating Cash Flow (204.9) (134.7) (70.2) (59.6) (65.5) (53.6) (77.6) (49.2) (50.5) (34.0)
Investing Activities
Capital Expenditure (12.0) (1.3) (6.1) (3.7) (1.2) (0.8) (2.2) (1.9) (8.3) (1.9)
Acquisitions 0 0 0 0 0 0 0 0 0.0 0.0
Purchases of Investments 0 0 0 0 0 0 0 0 (3) (41.7)
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 38.2 80.7
Other Investing Activities 0.1 0 0 0 0 0 0 0 0.1 (1.5)
Investing Cash Flow (11.9) (1.3) (6.1) (3.7) (1.2) (0.8) (2.2) (1.9) 27.1 35.6
Financing Activities
Net Debt Issuance 0 316.4 56.3 0 (0.4) 0 37.3 6.4 2.4 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 (300.6) (4.6) 0.5 2.3 3.3 0.5 0.7 0.4 (0.0)
Financing Cash Flow 561.7 332.1 169.8 1.5 2.9 228.0 75.3 68.6 32.0 0.6
Cash Position
Net Change in Cash 345.0 196.1 93.5 (61.9) (63.9) 173.6 (4.5) 17.5 8.6 2.2
Cash at Beginning 393.7 197.6 104.1 165.9 229.8 56.2 60.7 43.2 32.9 30.8
Cash at End 738.7 393.7 197.6 104.1 165.9 229.8 56.2 60.7 41.5 32.9
Free Cash Flow (216.9) (136.0) (76.3) (63.3) (66.7) (54.4) (79.8) (51.1) (58.7) (35.9)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Income Statement
Revenue 51.8 63.7 58.4 51.5 43.5 17.4 4.2 2.0 1.9 1.9 1.8 0.8 0 0.0
Gross Profit 45.2 58.1 53.2 47.0 39.1 15.3 1.9 1.5 1.5 1.4 1.4 0.7 (10.5) 0.0
Operating Income (270.0) (171.8) (82.4) (78.7) (78.0) (62.8) (85.8) (59.1) (61.9) (43.3) (38.2) (27.1) (12.9) (13.7)
Net Income (265.9) (193.5) (80.7) (71.0) (6.6) (155.6) (86.4) (57.7) (63.4) (44.7) (39.7) (28.6) (13.3) (14.1)
EPS (Diluted) -1.42 -1.22 -1.02 -0.97 -0.98 -2.56 -1.91 -1.57 -2.20 -1.80 -1.71 -2.69 -4.52 -4.78
Balance Sheet
Cash & Equivalents 737.1 392.1 195.8 102.3 164.2 228.1 54.4 54.1 41.5 32.9
Total Assets 808.1 457.9 252.1 149.3 204.9 261.9 78.7 73.0 55.4 74.9
Total Debt 79.8 75.8 83.4 64.3 59.0 58.4 59.3 24.8 18.0 15.6
Stockholders' Equity 654.3 315.3 91.1 35.4 88.0 76.1 (3.6) 35.9 26.1 52.0
Cash Flow
Operating Cash Flow (204.9) (134.7) (70.2) (59.6) (65.5) (53.6) (77.6) (49.2) (50.5) (34.0)
Capital Expenditure (12.0) (1.3) (6.1) (3.7) (1.2) (0.8) (2.2) (1.9) (8.3) (1.9)
Free Cash Flow (216.9) (136.0) (76.3) (63.3) (66.7) (54.4) (79.8) (51.1) (58.7) (35.9)